BioRestorative Therapies (BRTX)
Develops autologous cell therapies and cell-secretome cosmetics for spine and metabolic applications.
$2.62
After hours−0.05 (−1.87%)
At close$2.67(−1.48%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 10.46% | 133.3K shares | |
|---|---|---|---|
| 19 holders · as of Jun 30, 2026 | |||
| Insiders | 2.49% | 31.7K shares | |
| 2 holders · as of Oct 20, 2025 | |||
| Other | 87.05% | 1.11M shares | |
| remainder | |||
1.27M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
19 holders · 2.67M shares · 10 new positions · 14 increased · 1 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jane Street Group, LLC | 803.5K | 63.07% | +803.5Knew | Aug 14, 2026 |
| HRT Financial LP | 710.6K | 55.78% | +710.6Knew | Aug 14, 2026 |
| XTX Topco Ltd | 286.5K | 22.49% | +286.5Knew | Aug 14, 2026 |
| Citadel Advisors LLC | 273.3K | 21.45% | +34.7K | Sep 2, 2026 |
| Vanguard Fiduciary Trust Co | 181.3K | 14.23% | +141.8K | Aug 13, 2026 |
| Geode Capital Management, LLC | 152.4K | 11.96% | −70.7K | Aug 12, 2026 |
| Citigroup Inc | 63.7K | 5.00% | +63.7Knew | Aug 3, 2026 |
| Wealth Alliance | 40.0K | 3.14% | 0 | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Alstodt Lance | 15.50% | 13D | Feb 19, 2025 | |
| Silva, Francisco | 15.10% | 13D | Feb 19, 2025 | |
| Auctus Fund, LLC | 9.90% | 13G | May 15, 2026 | |
| Auctus Fund Management LLC | 9.90% | 13G | May 15, 2025 | |
| Alta Partners LLC | 7.70% | 13G | Feb 13, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.